Ibrance 125 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FXQ9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,110
Award facts
- Contract value 100% obligated
- $17,110.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of IBRANCE 125 mg tablets (7-count) valued at $17,110.44 under a firm fixed price contract type. The award was made on December 19, 2025, with an ultimate completion date of January 13, 2026. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle designated SPE2DX and running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order represents a routine pharmaceutical procurement supporting military and federal healthcare systems through AmerisourceBergen's established prime vendor relationship with DLA. IBRANCE is a prescription cancer treatment medication, consistent with AmerisourceBergen's broad portfolio of specialty medications, brand-name pharmaceuticals, and medical supplies delivered across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The firm fixed price structure and short delivery timeline reflect the critical and time-sensitive nature of pharmaceutical supply chain management within the federal medical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FXQ9B?
SPE2DR26FXQ9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FXQ9B worth?
The government has obligated $17,110 on SPE2DR26FXQ9B.
Is contract SPE2DR26FXQ9B an order under another contract?
Yes. SPE2DR26FXQ9B is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ9B competed?
The extent of competition for SPE2DR26FXQ9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award